News

Johnson & Johnson receives positive CHMP opinion of nipocalimab to treat a broad population of antibody-positive patients living with generalised myasthenia gravis (gMG)

Pending the European Commission’s final decision, nipocalimab could be the first FcRn blocker approved in both adult and adolescent gMG patients aged 12 and older who are anti-AChR or anti-MuSK ...

Tonix Pharmaceuticals Announces In-licensing Phase 2/3-Ready Monoclonal Antibody Designed for Seasonal Prevention of Lyme Disease (TNX-4800)

Positive Phase 1 study showed safety, tolerability and a linear pharmacokinetic: pharmacodynamic: efficacy relationship (1: 1: 1)Planning ...
Archives of Disease in Childhood

Consensus statement on the need for a specialist service for paediatric saliva control in neurodevelopmental disabilities

Poor saliva control (sialorrhoea) represents a considerable burden to paediatric patients with neurodevelopmental ...

Biomea Fusion Presents Data Demonstrating Enhanced Preclinical Activity of Icovamenib in Combination with Semaglutide in Type 2 Diabetes (T2D) Animal Model at the 61st EASD ...

In a rodent model of T2D, icovamenib in combination with low-dose semaglutide promoted enhanced glycemic control and body weight reduction with preservation of lean mass, outperforming the group given ...
SciELO

Effects of short-term isokinetic training with reciprocal knee extensors agonist and antagonist muscle actions: A controlled and randomized trial

BACKGROUND: Previous studies have shown that preloading an antagonist muscle may increase the acute agonist neuromuscular performance. In addition, studies have suggested that very short-term ...
News-Medical.Net

Sansho: A Japanese Spice Supporting Gut, Immune, And Metabolic Health

Discover how sansho, Japan’s tingling spice, bridges tradition and science with proven roles in gut balance, pain relief, and metabolic wellness.